Physician profile
Evan M Farina
NPI 1710417951
$35,175.88
in general payments reported to CMS, 2019-2025
11 companies · $87.11 in 2025
The $87.11 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,543 · 2020: $1,078 · 2021: $1,301 · 2022: $9,679 · 2023: $14K · 2024: $7,896 · 2025: $87.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,650 · Consulting Fee: $5,500 · Travel and Lodging: $3,569 · Honoraria: $2,788 · Food and Beverage: $2,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,650.00 |
| Consulting Fee | $5,500.00 |
| Travel and Lodging | $3,568.85 |
| Honoraria | $2,788.00 |
| Food and Beverage | $2,067.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15,490.27 | 2022-2023 | |
| Vericel Corporation | $7,591.28 | 2024 | Maci |
| Kairos Surgical INC | $5,431.36 | 2019-2023 | |
| Stryker Corporation | $4,379.44 | 2021-2025 | Salvation, Nanopass, Iconix |
| Arthrex, INC. | $1,310.73 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $788.00 | 2023 | Exparel |
| Bioventus LLC | $102.33 | 2024-2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Axogen | $45.84 | 2025 | Axoguard Ha+ Nerve Protector |
| Medical Device Business Services, INC. | $19.85 | 2023 | Healix Knotless Peek |
| Acumed LLC | $16.78 | 2024 | Acumed, Innate Implant |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Farina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.